First Time Loading...

Harvard Bioscience Inc
NASDAQ:HBIO

Watchlist Manager
Harvard Bioscience Inc Logo
Harvard Bioscience Inc
NASDAQ:HBIO
Watchlist
Price: 3.92 USD 1.82% Market Closed
Updated: May 7, 2024
Section:
 

Relative Value

The Relative Value of one HBIO stock under the Base Case scenario is 7.34 USD. Compared to the current market price of 3.92 USD, Harvard Bioscience Inc is Undervalued by 47%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HBIO Relative Value
Base Case
7.34 USD
Undervaluation 47%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.5
P/S
P/S
Price to Sales
1.5
vs History
49
vs Industry
77
Median 3Y
1.7
Median 5Y
1.5
Industry
3.9
Forward
1.5
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-54.8
Median 5Y
-47.2
Industry
31.1
Forward
18.6
More Details
12.1
P/OCF
P/OCF
Price to OCF
12.1
vs History
76
vs Industry
40
Median 3Y
22.2
Median 5Y
16.6
Industry
23.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
23
Median 3Y
-42.6
Median 5Y
-33.5
Industry
27.4
More Details
2.3
P/B
P/B
Price to Book Value
2.3
vs History
44
vs Industry
47
Median 3Y
2.6
Median 5Y
2.2
Industry
2.5
More Details
1.8
EV/S
EV/S
Enterprise Value to Sales
1.8
vs History
49
vs Industry
73
Median 3Y
2
Median 5Y
1.7
Industry
3.8
Forward
1.7
More Details
3
EV/GP
EV/GP
Enterprise Value to Gross Profit
3
vs History
52
vs Industry
74
Median 3Y
3.5
Median 5Y
3.1
Industry
7.9
More Details
21.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
21.2
vs History
77
vs Industry
24
Median 3Y
28.1
Median 5Y
26.2
Industry
17.2
Forward
11.3
More Details
86
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
86
vs History
33
vs Industry
4
Median 3Y
77.2
Median 5Y
64.7
Industry
22.7
Forward
51.4
More Details
14
EV/OCF
EV/OCF
Enterprise Value to OCF
14
vs History
80
vs Industry
38
Median 3Y
26.1
Median 5Y
20.2
Industry
21.4
More Details
16.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
16.8
vs History
71
vs Industry
31
Median 3Y
19
Median 5Y
20.9
Industry
27.9
More Details
1.5
EV/IC
EV/IC
Enterprise Value to IC
1.5
vs History
44
vs Industry
56
Median 3Y
1.7
Median 5Y
1.5
Industry
2.4
More Details

Multiples Across Competitors

HBIO Competitors Multiples
Harvard Bioscience Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Harvard Bioscience Inc
NASDAQ:HBIO
170.1m USD 1.5 -49.8 21.2 86
US
Thermo Fisher Scientific Inc
NYSE:TMO
222B USD 5.2 37 22.9 33.5
US
Danaher Corp
NYSE:DHR
183.3B USD 4.2 22.7 16.5 20.4
CH
Lonza Group AG
SIX:LONN
37.3B CHF 5.6 57 19.6 28.7
US
Agilent Technologies Inc
NYSE:A
41.2B USD 6.1 33.3 26.6 32
US
IQVIA Holdings Inc
NYSE:IQV
41.2B USD 2.8 30.3 16.5 25.6
KR
Samsung Biologics Co Ltd
KRX:207940
54.9T KRW 14.9 64 33.7 48.6
US
West Pharmaceutical Services Inc
NYSE:WST
26.8B USD 9.1 47.1 32.7 39.6
US
Mettler-Toledo International Inc
NYSE:MTD
26.9B USD 7.1 34.1 23.9 26.5
IE
ICON PLC
NASDAQ:ICLR
26.1B USD 3.2 38.1 17.2 26.4
FR
Sartorius Stedim Biotech SA
PAR:DIM
19B EUR 7 74.5 32.1 52.7

See Also

Summary
HBIO intrinsic value, competitors valuation, and company profile.
DCF Valuation
HBIO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HBIO stock valuation using valuation multiples.
Wall Street Estimates
HBIO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HBIO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.